BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15134597)

  • 1. Endothelial cells, antineutrophil cytoplasmic antibodies, and cytokines in the pathogenesis of systemic vasculitis.
    Cid MC; Segarra M; García-Martínez A; Hernández-Rodríguez J
    Curr Rheumatol Rep; 2004 Jun; 6(3):184-94. PubMed ID: 15134597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-endothelial cell antibodies in antineutrophil cytoplasmic antibodies negative pauci-immune crescentic glomerulonephritis.
    Cong M; Chen M; Zhang JJ; Hu Z; Zhao MH
    Nephrology (Carlton); 2008 Jun; 13(3):228-34. PubMed ID: 18315705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New developments in the pathogenesis of systemic vasculitis.
    Cid MC
    Curr Opin Rheumatol; 1996 Jan; 8(1):1-11. PubMed ID: 8867532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms and markers of vascular damage in ANCA-associated vasculitis.
    Haubitz M; Dhaygude A; Woywodt A
    Autoimmunity; 2009 Nov; 42(7):605-14. PubMed ID: 19863378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?
    Heeringa P; Tervaert JW
    Kidney Int; 2004 May; 65(5):1564-7. PubMed ID: 15086893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the endothelium in systemic small vessel vasculitis.
    Little MA; Savage CO
    Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S135-40. PubMed ID: 18799071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing concepts in pathophysiology of the vasculitides.
    Robertson CR; McCallum RM
    Curr Opin Rheumatol; 1994 Jan; 6(1):3-10. PubMed ID: 8031677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ANCA (antineutrophil cytoplasmic antibodies). Contribution of ANCA to the understanding of pathogenic mechanisms of systemic vasculitis].
    De Bandt M
    Ann Med Interne (Paris); 1997; 148(8):542-62. PubMed ID: 9538401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineutrophil cytoplasmic antibodies: major autoantigens, pathophysiology, and disease associations.
    Schultz DR; Tozman EC
    Semin Arthritis Rheum; 1995 Dec; 25(3):143-59. PubMed ID: 8650585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for antineutrophil cytoplasmic antibody-associated vasculitis: challenging the therapeutic status quo?
    Bosch X; Guilabert A; Espinosa G; Mirapeix E
    Trends Immunol; 2008 Jun; 29(6):280-9. PubMed ID: 18440274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neutrophil in antineutrophil cytoplasmic autoantibody-associated vasculitis.
    Schreiber A; Kettritz R
    J Leukoc Biol; 2013 Oct; 94(4):623-31. PubMed ID: 23381471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of anti-neutrophil cytoplasm antibodies in systemic vasculitis and other related disorders.
    Pradhan VD; Badakere SS; Iyer YS; Kumar R; Almeida AF
    J Postgrad Med; 2003; 49(1):5-9; discussion 9-10. PubMed ID: 12865563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?
    Tervaert JW; Heeringa P
    Neth J Med; 2003 Dec; 61(12):404-7. PubMed ID: 15025415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trafficking of QD-conjugated MPO-ANCA in murine systemic vasculitis and glomerulonephritis model mice.
    Hoshino A; Nagao T; Ito-Ihara T; Ishida-Okawara A; Uno K; Muso E; Nagi-Miura N; Ohno N; Tokunaka K; Naoe S; Hashimoto H; Yasuhara M; Yamamoto K; Suzuki K
    Microbiol Immunol; 2007; 51(5):551-66. PubMed ID: 17579266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vasculitis--aspect of cellular and molecular pathogenesis].
    Gröne HJ
    Verh Dtsch Ges Pathol; 2001; 85():142-52. PubMed ID: 11894391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial damage and repair in antineutrophil cytoplasmic antibody-associated vasculitis.
    de Groot K; Goldberg C; Bahlmann FH; Woywodt A; Haller H; Fliser D; Haubitz M
    Arthritis Rheum; 2007 Nov; 56(11):3847-53. PubMed ID: 17968939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineutrophil cytoplasmic antibodies (ANCA) and systemic vasculitis: update of assays, immunopathogenesis, controversies, and report of a novel de novo ANCA-associated vasculitis after kidney transplantation.
    Schultz DR; Diego JM
    Semin Arthritis Rheum; 2000 Apr; 29(5):267-85. PubMed ID: 10805352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis.
    Gross WL; Csernok E
    Curr Opin Rheumatol; 1995 Jan; 7(1):11-9. PubMed ID: 7718417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What you should know about PR3-ANCA. Evidence for the role of T cells in the pathogenesis of systemic vasculitis.
    Clayton AR; Savage CO
    Arthritis Res; 2000; 2(4):260-2. PubMed ID: 11094438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: Leukocyte-endothelial dysregulation in systemic small vessel vasculitis.
    Pankhurst T; Savage CO; Little MA
    Nephrology (Carlton); 2009 Feb; 14(1):3-10. PubMed ID: 19143939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.